(Q40373514)

19 September 2017

Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation (English)

1 reference

19 September 2017

6

Annemie M W J Schols

1 reference

19 September 2017

4

Emiel F M Wouters

1 reference

Yvonne M W Janssen-Heininger

19 September 2017

5

object named as

Yvonne M W Janssen-Heininger

1 reference

19 September 2017

Jos L J van der Velden

1

1 reference

19 September 2017

Ramon C J Langen

2

1 reference

19 September 2017

Marco C J M Kelders

3

1 reference

19 September 2017

14 September 2005

1 reference

American Journal of Physiology - Cell Physiology

19 September 2017

1 reference

19 September 2017

290

1 reference

19 September 2017

C453-62

1 reference

19 September 2017

2

1 reference

beta-catenin is a target for the ubiquitin-proteasome pathway

19 September 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Plasticity of myonuclear number in hypertrophied and atrophied mammalian skeletal muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Myonuclear domains in muscle adaptation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Wasting as independent risk factor for mortality in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

The role of cytokines in cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Wnt signaling and the activation of myogenesis in mammals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

GSK-3: tricks of the trade for a multi-tasking kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Proliferation precedes differentiation in IGF-I-stimulated myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Molecular mechanisms modulating muscle mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Inhibition of MAP/ERK kinase prevents IGF-I-induced hypertrophy in rat muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

IL-4 acts as a myoblast recruitment factor during mammalian muscle growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

IGF-1 induces human myotube hypertrophy by increasing cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Glycogen synthase kinase-3 is the predominant insulin-regulated eukaryotic initiation factor 2B kinase in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

A molecular mechanism for the effect of lithium on development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Enhanced myogenic differentiation by extracellular matrix is regulated at the early stages of myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

mTOR-dependent control of skeletal muscle protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Satellite cell of skeletal muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Beta-catenin is essential and sufficient for skeletal myogenesis in P19 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

IGF-I is required for normal embryonic growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Insulin-like growth factor-I in muscle metabolism and myotherapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

GSK-3beta negatively regulates skeletal myotube hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

A Myogenic Cell Line with Altered Serum Requirements for Differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00068.2005

10.1152/AJPCELL.00068.2005

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference